Achieve reliable procedural success with the VBX Stent Graft.⁠1⁠,⁠2

The VBX Stent Graft has been proven across years of study in a comprehensive clinical development program, in hundreds of bEVAR and fEVAR procedures both in the Gore EMBRACE and EXPAND Registries.b,1,2
people-group-black

371

patients

hospital-black

Across 29

centers

Study designs

The EMBRACE study was a multicenter, single-arm retrospective and prospective Registry, conducted to confirm the clinical performance and safety of the VBX Stent Graft for fEVAR and bEVAR in the treatment of aortic aneurysms involving the renal-mesenteric arteries.1

The EXPAND study was a post-market registry, evaluating the safety and performance data of the VBX Stent Graft for fEVAR and bEVAR in peripheral vessels in patients who require interventional treatment.2

EMBRACE Registry
(1-year outcomes)
(n=259)  
EXPAND Registry
(3-year outcomes)
(n=112)
Target vessel technical successa,1,2Target vessel technical successa,1,2
bEVAR 99.6%bEVAR 100%
fEVAR 100%fEVAR 100%
Primary patency1,2Primary patency1–3
bEVAR 98.9% bEVAR 93.6%
fEVAR 99.4% fEVAR 94.7%
Freedom from target vessel instability1,2 Freedom from target vessel instability1-3 
bEVAR 94.5%bEVAR 94.5%
fEVAR 96.6% fEVAR 94.9% 

The VBX Stent Graft is stable and durable, made for repairs that last.⁠1⁠–⁠3

a Procedural outcomes based on usage of legacy GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (BXA catalogue numbers).
b The EMBRACE Registry enrolled 259 patients. The EXPAND Registry enrolled 112 patients in the fEVAR and bEVAR cohorts.1,2

  1. W. L. Gore & Associates. Post-Market Registry of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Implanted in Peripheral Vessels (EXPAND). VBX 17-04. Published December 18, 2018. Updated February 16, 2024. Accessed July 26, 2025. https://clinicaltrials.gov/study/NCT03720704
  2. W. L. Gore & Associates. Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used as a Bridging Stent with Branched and Fenestrated Endografts in the Treatment of Aortic Aneurysms Involving the Renal-Mesenteric Arteries (EMBRACE). VBX 21-04. Published March 23, 2022. Updated January 1, 2025. Accessed July 26, 2025. https://clinicaltrials.gov/study/NCT05143138
  3. Usai MV, Gargiulo M, Haulon S, et al. A three-year experience with the balloon expandable GORE VIABAHN VBX in the treatment of thoraco-abdominal aortic aneurysms within the EXPAND trial. Journal of Vascular Surgery 2025;81(2):319–323.
IFU Consult instructions

Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly

INDICATIONS FOR USE IN EUROPE: The GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis is indicated for the treatment of: 

  • de novo or restenotic lesions found in iliac arteries, including lesions at the aortic bifurcation;
  • de novo or restenotic lesions in the visceral arteries;
  • isolated visceral, iliac, and subclavian artery aneurysms; or
  • traumatic or iatrogenic vessel injuries in arteries that are located in the chest cavity, abdominal cavity, or pelvis (except for aorta, coronary, innominate, carotid, vertebral, and pulmonary arteries).

The GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis is indicated for use as a bridging stent in branched and fenestrated endovascular aortic aneurysm repair with the followingc:

  • Approved for use branched aortic endovascular grafts constructed of polyester fabric, stainless steel stents, and polypropylene suture with branch diameters of 6/8 mm and lengths of 18/21 mm.
  • Approved for use fenestrated aortic endovascular grafts constructed of polyester fabric, stainless steel stents, and fenestrations with polypropylene suture ranging in diameter from 6–8 mm.

CONTRAINDICATIONS: Do not use the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis in patients with known hypersensitivity to heparin, including those patients who have had a previous incident of Heparin-Induced Thrombocytopenia (HIT) type II.

c Not applicable to Reduced Profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (BXB catalogue numbers).  

Product may not be available in all countries. Please check with your Gore representative for availability.
25PL2235-EN02